Type : Contract
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
This is a non-personal services contract to provide surveillance or research services in the assessment of infectious diseases on the continent of Africa; including, but not limited to, Ethiopia, Kenya, Nigeria, Somalia, Tanzania, Uganda.Amendment 0001 answers questions and provides revised documents (SOW, Attachements 6 & 7, and changes to section L of the solicitation).
To survey and characterize etiologic agents of infectious disease, including those causing febrile vector-borne infections (FVBI), respiratory infections (RI), enteric infections (EI), sexually transmitted infections (STI), and antimicrobial resistant bacterial infections (AMR).
PART I: OVERVIEW Department Office/Division/Program: MCDCP/Infectious Disease Surveillance/HIV Prevention Department Contract Administrator or Grant Coordinator: Chris Moiles / Patti Wall (If applicable) Department Reference #: Multiple (See Attached Table) Amount: (Contract/Amendment/Grant) See Attached Table Advantage CT / RQS #: See Attached Table CONTRACT Proposed Start Date: 9/01/2020 Proposed End Date: 6/30/2021 AMENDMENT Original Start Date
PART I: OVERVIEW Department Office/Division/Program: MCDCP/Infectious Disease Surveillance/HIV Prevention Department Contract Administrator or Grant Coordinator: Chris Moiles / Patti Wall (If applicable) Department Reference #: CDM-21-5104B Amount: (Contract/Amendment/Grant) Orig: $323,446.00 Amend $20,000.00 Revised: $343,446.00 Advantage CT / RQS #: CT-10A-20200804000000000367 CONTRACT Proposed Start Date: Proposed End Date: AMENDMENT Original Start
oppId=343685Proposals/applications to the FY22 Joint Program Committee 2/Military Infectious Diseases Research Program (JPC-2/MIDRP) and JPC-6/Combat Casualty Care Research Program (CCCRP) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by 10 USC 4001.
Contractor shall be responsible for allocating all equipment and personnel, including back-up resources, to meet all requirements for the comprehensive management of the solid waste, recycling programs, infectious waste, pharmaceutical waste, and universal waste at the George H. O'Brien Jr.